Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation

Asian Journal of Andrology

Volumn 14, Issue 2, 2012, Pages 247-250

  Gundacker, Claudia ^a   Dolznig, Helmut ^a   Mikula, Mario ^a   Rosner, Margit ^a   Brandau, Oliver ^a   Hengstschläger, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

amniotic fluid; human genetics; infertility; primordial germ cells; reproduction; spermatogenesis; stem cells; toxicity

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TOXIC SUBSTANCE;

AMNIOCENTESIS; AMNIOTIC FLUID CELL; AMNIOTIC FLUID STEM CELL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC STEM CELL; EPIGENETICS; GAMETE; GENE FUNCTION; GENE MUTATION; GENETIC SCREENING; GENETIC TRANSFECTION; GERM CELL; HUMAN; MALE; MALE INFERTILITY; NONHUMAN; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; REPRODUCTIVE TOXICITY; REVIEW; SPERMATOGENESIS; STEM CELL;

AMNIOTIC FLUID; ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; MALE; MICE; MODELS, ANIMAL; MUTATION; PLURIPOTENT STEM CELLS; SPERMATOGENESIS;

EID: 84858029207     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.170     Document Type: Review

References (75)

1. Sassone-Corsi P. Stem cells of the germline: the specialized facets of their differentiation program. Cell Cycle 2008; 7: 3491-2.
2. Phillips BT, Gassei K, Orwig KE. Spermatogonial stem cell regulation and spermatogenesis. Philos Trans R Soc Lond B Biol Sci 2010; 365: 1663-78.
3. Yoshida S. Stem cells in mammalian spermatogenesis. Dev Growth Differ 2010; 52: 311-7.
4. Kee K, Pera RA, Turek PJ. Testicular germline stem cells. Nat Rev Urol 2010; 7: 94-100.
5. Panula S, Medrano JV, Kee K, Bergström R, Nguyen HN et al. Human germ cell differentiation from fetal- and adult-derived induced pluripotent stem cells. Hum Mol Genet 2011; 20: 752-62.
6. Menken J, Larsen U. Estimating the incidence and prevalence and analyzing the correlates of infertility and sterility. Ann NY Acad Sci 1994; 709: 249-65. (Pubitemid 24123346)
7. Hunt PA, Hassold TJ. Sex matters in meiosis. Science 2002; 296: 2181-3. (Pubitemid 34680292)
8. Zinn AR, Page DC, Fisher EM. Turner syndrome: the case of the missing sex chromosome. Trends Genet 1993; 9: 90-3. (Pubitemid 23062574)
9. Davison RM, Davis CJ, Conway GS. The X chromosome and ovarian failure. Clin Endocrinol 1999; 51: 673-9. (Pubitemid 30050815)
10. Saitou M, Barton SC, Surani MA. A molecular programme for the specification of germ cell fate in mice. Nature 2002; 418: 293-300. (Pubitemid 34790674)
11. Clark AT, Rodriguez RT, Bodnar MS, Abeyta MJ, Cedars MI et al. Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells 2004; 22: 169-79. (Pubitemid 38282632)
12. Reijo R, Lee TY, Salo P, Alagappan R, Brown LG et al. Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet 1995; 10: 383-93.
13. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L et al. The malespecific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003; 423: 825-37. (Pubitemid 36781267)
14. Hübner K, Fuhrmann G, Christenson LK, Kehler J, Reinbold R et al. Derivation of oocytes from mouse embryonic stem cells. Science 2003; 300: 1251-6. (Pubitemid 36618231)
15. Toyooka Y, Tsunekawa N, Akasu R, Noce T. Embryonic stem cells can form germ cells in vitro. Proc Natl Acad Sci USA 2003; 100: 11457-62. (Pubitemid 37205957)
16. Geijsen N, Horoschak M, Kim K, Gribnau J, Eggan K et al. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature 2004; 427: 148-54. (Pubitemid 38094954)
17. Clark AT, Bodnar MS, Fox M, Rodriquez RT, Abeyta MJ et al. Spontaneous differentiation of germ cells from human embryonic stem cells in vitro. Hum Mol Genet 2004; 13: 727-39. (Pubitemid 38455960)
18. Kee K, Gonsalves JM, Clark AT, Pera RA. Bonemorphogenetic proteins induce germ cell differentiation from human embryonic stem cells. Stem Cells Dev 2006; 15: 831-7. (Pubitemid 46147855)
19. Tilgner K, Atkinson SP, Golebiewska A, Stojkovic M, Lako M et al. Isolation of primordial germ cells from differentiating human embryonic stem cells. Stem Cells 2008; 26: 3075-85.
20. Bucay N, Yebra M, Cirulli V, Afrikanova I, Kaido T et al. A novel approach for the derivation of putative primordial germ cells and Sertoli cells from human embryonic stem cells. Stem Cells 2009; 27: 68-77.
21. Aflatoonian B, Ruban L, Jones M, Aflatoonian R, Fazeli A et al. In vitro post-meiotic germ cell development from human embryonic stem cells. Hum Reprod 2009; 24: 3150-9.
22. Park TS, Galic Z, Conway AE, Lindgren A, van Handel BJ et al. Derivation of primordial germ cells from human embryonic and induced pluripotent stem cells is significantly improved by coculture with human fetal gonadal cells. Stem Cells 2009; 27: 783-95.
23. Imamura M, Aoi T, Tokumasu A, Mise N, AbeKet al. Induction of primordial germ cells from mouse induced pluripotent stem cells derived from adult hepatocytes. Mol Reprod Dev 2010; 77: 802-11.
24. Hayashi K, Ohta H, Kurimoto K, Aramaki S, Saitou M. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell 2011; 146: 519-32.
25. Koshimizu U, Watanabe M, Nakatsuji N. Retinoic acid is a potent growth activator of mouse primordial germ cells in vitro. Dev Biol 1995; 168: 683-5.
26. Castrillon DH, Quade BJ, Wang TY, Quigley C, Crum CP. The human VASA gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci USA 2000; 97: 9585-90. (Pubitemid 30650819)
27. Kee K, Angeles VT, Flores M, Nguyen HN, Reijo Pera RA. Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation. Nature 2009; 462: 222-5.
28. Julaton VT, Reijo Pera RA. NANOS3 function in human germ cell development. Hum Mol Genet 2011; 20: 2238-50.
29. Lucas B, Fields C, Hofmann MC. Signaling pathways in spermatogonial stem cells and their disruption by toxicants. Birth Defects Res C Embryo Today 2009; 87: 35-42.
30. Krtolica A, Giritharan G. Use of human embryonic stem cell-based models for male reproductive toxicity screening. Syst Biol Reprod Med 2010; 56: 213-21.
31. Kee K, Flores M, Cedars MI, Reijo Pera RA. Human primordial germ cell formation is diminished by exposure to environmental toxicants acting through the AHR signaling pathway. Toxicol Sci 2010; 117: 218-24.
32. Prusa A, Marton E, Rosner M, Bernaschek G, Hengstschläger M. Oct-4 expressing cells in human amniotic fluid: a new source for stem cell research?HumReprod 2003; 18: 1489-93. (Pubitemid 36840959)
33. in't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102: 1548-9. (Pubitemid 36988070)
34. Prusa AR, Marton E, Rosner M, Freilinger A, Bernachek G et al. Stem cell marker expression in human trisomy 21 amniotic fluid cells and trophoblasts. J Neural Transm 2003; 67: 235-42. (Pubitemid 38339938)
35. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004; 19: 1450-6.
36. Prusa AR, Marton E, Rosner M, Bettelheim D, Lubec G et al. Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol 2004; 191: 309-14. (Pubitemid 39077994)
37. Karlmark KR, Freilinger A, Marton E, Rosner M, Lubec G et al. Activation of Oct-4 and Rex-1 promoters in human amniotic fluid cells. Int J Mol Med 2005; 16: 987-92.
38. Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL et al. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006; 74: 545-51.
39. Bossolasco P, Montemurro T, Cova L, Zangrossi S, Calzarossa C et al. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 2006; 16: 329-36.
40. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007; 40: 75-90. (Pubitemid 46103692)
41. De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos TX et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100-6. (Pubitemid 46087908)
42. Kolambkar YM, Peister A, Soker S, Atala A, Guldberg RE. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Hist 2007; 38: 405-13. (Pubitemid 350056771)
43. Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R et al. Human and murine amniotic c-Kit1Lin2 cells display hematopoietic activity. Blood 2009; 113: 3953-60.
44. Perin L, Giuliani S, Jin D, Sedrakyan S, Carraro G et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif 2007; 40: 936-48. (Pubitemid 350139201)
45. Siegel N, Valli A, Fuchs C, Rosner M, Hengstschläger M. Induction of mesenchymal/epithelial marker expression in human amniotic fluid stem cells. RBM Online 2009; 19: 838-46.
46. Siegel N, Rosner M, Unbekandt M, Fuchs C, Slabina N et al. Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. Hum Mol Genet 2010; 19: 3320-31.
47. Perin L, Sedrakyan S, Giuliani S, DaSacco S, Carraro G et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS ONE 2010; 5: 1-16
48. Hauser PV, DeFazio R, Bruno S, Sdei S, Grange C et al. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol 2010; 177: 2011-21.
49. Valli A, Rosner M, Fuchs C, Siegel N, Bishop CE et al. Embryoid body formation of human amniotic fluid stem cells depends on mTOR. Oncogene 2010: 29: 966-77.
50. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-7. (Pubitemid 28516247)
51. Kamm FM. Ethical issues in using and not using embryonic stem cells. Stem Cell Rev 2005; 1: 325-30. (Pubitemid 44195968)
52. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76. (Pubitemid 44233629)
53. Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev 2010; 24: 2239-63.
54. Mattis V, Svendsen CN. Induced pluripotent stem cells: a new revolution for clinical neurology? Lancet Neurol 2011; 10: 383-94.
55. Kim K, Doi A, Wen B, Ng K, Zhao R et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467: 285-90.
56. Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010; 465: 175-81.
57. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011; 8: 106-18.
58. Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7: 521-31.
59. Gore A, Li Z, Fung HL, Young JE, Agarwal S et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011; 471: 63-7.
60. Pasi CE, Dereli-Öz A, Negrini S, Friedli M, Fragola G et al. Genomic instability in induced stem cells. Cell Death Differ 2011; 18: 745-53.
61. Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 2009; 4: 423-33.
62. Dobreva P, Pereira PN, Deprest J, Zwijsen A. On the origin of amniotic stem cells: of mice and men. Int J Dev Biol 2010; 54: 761-77.
63. Zhu H, Lensch WM, Cahan P, Daley GQ. Investigating monogenic and complex diseases with pluripotent stem cells. Nat Rev Genet 2011; 12: 266-75.
64. Rosner M, Dolznig H, Schipany K, Mikula M, Brandau O et al. Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis. Oncotarget 2011; 2: 705-12.
65. Verlinsky Y, Strelchenko N, Kukharenko V, Rechitsky S, Verlinsky O et al. Human embryonic stem cell lines with genetic disorders. Reprod Biochem Online 2004; 10: 105-10.
66. Ben-Yosef D, Malcov M, Eiges R. PGD-derived human embryonic stem cell lines as a powerful tool for the study of human genetic disorders. Mol Cell Endocrinol 2008; 282: 153-8.
67. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321: 1218-21.
68. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T et al. Disease-specific induced pluripotent stem cells. Cell 2008; 134: 877-86.
69. Raymond FL, Whittaker J, Jenkins L, Lench N, Chitty LS. Molecular prenatal diagnosis: the impact of modern technologies. Prenat Diagn 2010; 30: 674-81.
70. Stefanidis K, Loutradis D, Koumbi L, Anastasiadou V, Dinopoulou V et al. Deleted in Azoospermia-Like (DAZL) gene-expressing cells in human amniotic fluid: a new source for germ cells research? Fertil Steril 2008; 90: 798-804.
71. Rosner M, Siegel N, Fuchs C, Slabina N, Dolznig H et al. Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nat Protoc 2010; 5: 1081-95.
72. Apostoli P, Kiss P, Porru S, Bonde JP, Vanhoorne M. Male reproductive toxicity of lead in animals and humans. ASCLEPIOS Study Group. Occup Environ Med 1998; 55: 364-74. (Pubitemid 28258933)
73. Choy CM, Lam CW, Cheung LT, Briton-Jones CM, Cheung LP et al. Infertility, blood mercury concentrations and dietary seafood consumption: a case-control study. BJOG 2002; 109: 1121-5. (Pubitemid 35287081)
74. Gundacker C, Gencik M, Hengstschläger M. The relevance of the individual genetic background for the toxicokinetics of two significant neurodevelopmental toxicants: mercury and lead. Mutat Res 2010; 705: 130-40.
75. Gundacker C, Scheinast M, Damjanovic L, Fuchs C, Rosner M et al. Proliferation potential of human amniotic fluid stem cells differently responds to mercury and lead exposure. Amino Acids; e-pub ahead of print 19 November 2011; doi: 10.1007/s00726-011-1154-1.